(Q51351891)

4 April 2018

title

Topical vascular endothelial growth factor reverses delayed wound healing secondary to angiogenesis inhibitor administration. (English)

1 reference

4 April 2018

main subject

endothelium

0 references

angiogenesis inhibitor

1 reference

1 reference

7

Geoffrey C Gurtner

1 reference

4 April 2018

author name string

Joseph Michaels

1

1 reference

4 April 2018

Michael Dobryansky

2

1 reference

4 April 2018

Robert D Galiano

3

1 reference

4 April 2018

Kirit A Bhatt

4

1 reference

4 April 2018

Russell Ashinoff

5

1 reference

4 April 2018

Daniel J Ceradini

6

1 reference

4 April 2018

publication date

1 September 2005

1 reference

4 April 2018

Wound Repair and Regeneration

published in

1 reference

4 April 2018

volume

13

1 reference

4 April 2018

issue

5

1 reference

4 April 2018

page(s)

506-512

1 reference

4 April 2018

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

E-selectin is required for the antiangiogenic activity of endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

Angiogenesis: regulators and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

21 January 2018

Cutaneous wound healing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

Endostatin inhibits ischemia-induced neovascularization and increases ischemic tissue loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

Quantitative and reproducible murine model of excisional wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

Zinc ligand-disrupted recombinant human Endostatin: potent inhibition of tumor growth, safety and pharmacokinetic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

The Angiogenesis Inhibitor, Endostatin, Does Not Affect Murine Cutaneous Wound Healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1067-1927.2005.00071.X

10.1111/J.1067-1927.2005.00071.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018